Skip to content

VanishPoint® 10134

by Retractable Technologies, Inc.

VanishPoint® 10134 is a Class II device made by Retractable Technologies, Inc., cleared under FDA 510(k) K980069 on 12 Feb 1998 and listed in FDA GUDID since 22 Sep 2016 (UDI-DI 00613703101334), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K980069

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00613703101334 UDI-DI Date22 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k) from GUDID NumberK980069 Date12 Feb 1998IssuedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K980069 decided 12 Feb 1998 Active
  • FDA GUDID UDI-DI 00613703101334 listed 22 Sep 2016 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K980069
  2. Listed FDA GUDID 00613703101334

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
VanishPoint®
Generic name
Metered-delivery hypodermic syringe/needle
Model / Ref / Catalog
10134
Primary DI / UDI-DI
00613703101334
510(k) Number
FDA product code
MEG
GMDN term
Metered-delivery hypodermic syringe/needle
Device class
Class II
Regulation number
880.5860
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code MEG (Syringe, Antistick).

Other devices from Retractable Technologies, Inc.

See all devices from Retractable Technologies, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Lot / batch number
  • Expiration date
  • Manufacturing date
Other properties (10, all answered No)